Akero Therapeutics, Inc.

NASDAQ:AKRO

27.82 (USD) • At close December 31, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q12017 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 316.065310.355623.854234.207269.546444.156257.884249.773374.003177.727150.489150.483164.935157.538187.96187.242192.67963.24747.245136.4147.835162.65469.79675.9757.832-0.5980.598
Short Term Investments 401.182449.839279.811315.803285.186195.28885.338101.67602.99814.88737.77550.14672.4962.02481.14599.19139.58678.0471.612000001.1960
Cash and Short Term Investments 717.247760.194903.665550.01554.732639.444343.222351.449374.003180.725165.376188.258215.081230.028249.984268.387291.87102.833125.285136.4147.835162.65469.79675.9757.8320.5980.598
Net Receivables 000000000000000000000000000
Inventory 000000000000000000000000000
Other Current Assets 29.64115.8167.6159.95221.2473.7594.2677.4487.8866.8445.11610.64813.45212.38811.5845.91612.32620.721.8663.2984.4760.9081.8062.3120.60300.04
Total Current Assets 746.888776.01911.28559.962575.979643.203347.489355.173377.946184.147167.934193.582221.807236.222255.776271.345298.033113.193126.218138.049150.073163.10870.69977.1318.4350.5980.638
Non-Current Assets:
Property, Plant & Equipment, Net 0.8350.90.9631.0261.0881.1521.2211.2891.3541.421.4851.5491.6121.6721.7321.7931.84700.22600000000
Goodwill 000000000000000000000000000
Intangible Assets 000000000000000000000000000
Goodwill and Intangible Assets 000000000000000000000000000
Long Term Investments 69.82488.133019.28358.26419.451000000000000000000000
Tax Assets 000000000000000000000000000
Other Non-Current Assets 000-0000.1080.1080.1080.1080.4680.4170.1140.1150.1150.2010.1560.8650.1770.0690.070.061.3670.020.02-0.5980.02
Total Non-Current Assets 70.65989.0330.96320.30959.35220.6031.3291.3971.4621.5281.9531.9661.7261.7871.8471.9942.0030.8650.4030.0690.070.061.3670.020.02-0.5980.02
Total Assets 817.547865.043912.243580.271635.331663.806348.818356.57379.408185.675169.887195.548223.533238.009257.623273.339300.036114.058126.621138.118150.143163.16872.06677.1518.45500.658
Liabilities & Equity:
Current Liabilities:
Account Payables 25.22314.56813.7837.03811.45410.1217.087.9686.016.8774.456.7066.7842.3074.6053.4284.6362.5361.5350.9470.0933.2480.9521.3730.51900.06
Short Term Debt 0.6310.6290.640.5222.5810.4930.410.3250.3030.2550.2120.2050.1990.2270.3370.2940.30300.230.0850000000
Tax Payables 000000000000000000000000000
Deferred Revenue 0000-0.505-0.493000-0.255000000006.395-0.0850000000
Other Current Liabilities 17.43715.97715.83611.56814.41210.9889.18810.7918.9319.56517.43518.21716.55713.9255.1949.3897.0757.8576.5218.3376.6321.4921.4520.9690.500.162
Total Current Liabilities 43.29131.17430.25919.12828.44721.60216.67819.08325.24326.69722.09725.12823.5416.45910.13613.11112.01410.3938.2869.3696.7254.742.4042.3421.01900.222
Non-Current Liabilities:
Long Term Debt 35.72835.63835.55325.78323.65625.68225.63310.6210.58710.5652.512.6222.732.8342.9343.0323.1280000000000
Deferred Revenue Non-Current 000000000000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000000000000
Other Non-Current Liabilities 0.2030.1640.1780.0540.0930.0850.1620.3050.070.041-1.255-1.311-1.365-1.417-1.467-1.516-1.5640.0020.0120.0230.0340.0390124.728000
Total Non-Current Liabilities 35.93135.80235.73125.83723.74925.76725.79510.92510.65710.6061.2551.3111.3651.4171.4671.5161.5640.0020.0120.0230.0340.0390.952124.728000
Total Liabilities 79.22266.97665.9944.96552.19647.36942.47330.00835.937.30323.35226.43924.90517.87611.60314.62713.57810.3958.2989.3926.7594.7792.404127.071.01900.222
Equity:
Preferred Stock 00000000000000000000150.143163.168124.728124.72829.85855
Common Stock 0.0070.0070.0070.0060.0060.0060.0050.0050.0050.0040.0040.0040.0040.0040.0040.0040.0040.0030.0030.0030.0030.0030.0020000
Retained Earnings -756.132-683.427-627.44-574.096-518.91-479.251-448.168-422.337-399.278-363.736-336.333-310.304-277.88-253.55-224.617-209.527-179.816-158.413-142.206-130.32-114.709-99.155-91.927-86.565-25.0930-4.564
Accumulated Other Comprehensive Income/Loss 2.103-0.261-0.0790.27-0.506-0.2510.0210.0370-0.003-0.03-0.027-0.017-0.009-0.002-0.0030.0160.090.045-0.006-150.143-163.168000-4.5640
Other Total Stockholders Equity 1,492.3471,481.7481,473.7651,109.1261,102.5451,095.933754.487748.857742.781512.107482.894479.436476.521473.688470.635468.238466.254261.983260.481259.049408.233420.70936.861-88.082000
Total Shareholders Equity 738.325798.067846.253535.306583.135616.437306.345326.562343.508148.372146.535169.109198.628220.133246.02258.712286.458103.663118.323128.726143.384158.38969.662-49.9194.7650.4360.436
Total Equity 738.325798.067846.253535.306583.135616.437306.345326.562343.508148.372146.535169.109198.628220.133246.02258.712286.458103.663118.323128.726143.384158.38969.662-49.9194.7650.4360.436
Total Liabilities & Shareholders Equity 817.547865.043912.243580.271635.331663.806348.818356.57379.408185.675169.887195.548223.533238.009257.623273.339300.036114.058126.621138.118150.143163.16872.06677.1515.7840.4360.658